Catalyst Pharmaceuticals, Inc. (CPRX)
31.18
+0.02
(+0.06%)
USD |
NASDAQ |
May 15, 16:00
31.18
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap : 3.816B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 1.917B |
| Inovio Pharmaceuticals, Inc. | 106.96M |
| United Therapeutics Corp. | 24.13B |
| Regeneron Pharmaceuticals, Inc. | 73.20B |
| Agios Pharmaceuticals, Inc. | 1.675B |
Market Cap Related Metrics
| PE Ratio | 17.92 |
| PS Ratio | 6.646 |
| PEG Ratio | 1.626 |
| Price to Book Value | 3.768 |
| Price to Free Cash Flow | 19.06 |
| Price | 31.18 |
| Earnings Yield | 5.58% |
| PEGY Ratio | 1.626 |
| Operating PE Ratio | 14.82 |
| Normalized PE Ratio | 18.10 |